CervoMed (CRVO) Net Margin (2011 - 2025)
CervoMed's Net Margin came in at -92680.38% for Q4 2025, down 92370.21 percentage points from -310.17% a year earlier and down 90285.04 percentage points from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Net Margin (2011 - 2025) Analysis & Trends
For FY2025, CervoMed's Net Margin was -673.06%, down 505.77 percentage points from FY2024.
- Going back by year, Net Margin was -167.29% in FY2024 (-136.89 pp) and -30.40% in FY2023.
- The Q4 2025 figure represents the lowest quarterly Net Margin in data going back to Q3 2011.
- Year-over-year, Net Margin has declined for six consecutive quarters, with an average year-over-year change of -11912.40 percentage points over the last eight quarters.
- The fastest year-over-year change in Net Margin over five years came in Q2 2024 (a gain of 12.44 percentage points), and the weakest in Q4 2025 (a drop of 92370.21 percentage points).
- Business Quant data shows CRVO's Net Margin at -2395.34% (Q3 2025), -356.05% (Q2 2025) and -255.23% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | CervoMed | 27.35 Mn | 27.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -92,680.38% |
| Sep 30, 2025 | -2,395.34% |
| Jun 30, 2025 | -356.05% |
| Mar 31, 2025 | -255.23% |
| Dec 31, 2024 | -310.17% |
| Sep 30, 2024 | -245.06% |
| Jun 30, 2024 | -70.44% |
| Mar 31, 2024 | -107.12% |
| Dec 31, 2023 | -94.85% |
| Sep 30, 2023 | -172.15% |
| Jun 30, 2023 | -82.88% |
| Mar 31, 2023 | -37.95% |
| Jun 30, 2013 | 3,209.62% |
| Sep 30, 2012 | -14,860.50% |
| Jun 30, 2012 | -1,005.92% |
| Mar 31, 2012 | -260.21% |
| Dec 31, 2011 | -4,508.60% |
| Sep 30, 2011 | -1,733.00% |
API Access
CervoMed Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();